Literature DB >> 31825666

Upregulation of mitochondrial E3 ubiquitin ligase 1 in rat heart contributes to ischemia/reperfusion injury.

Shi-Jing Wang1,2, Heng Chen1, Li-Jing Tang1, Hua Tu1, Bin Liu3, Nian-Sheng Li1, Xiu-Ju Luo2, Jun Peng1,4.   

Abstract

Mitochondrial dysfunctions are responsible for myocardial injury upon ischemia/reperfusion (I/R), and mitochondrial E3 ubiquitin ligase 1 (Mul1) plays an important role in maintaining mitochondrial functions. This study aims to explore the function of Mul1 in myocardial I/R injury and the underlying mechanisms. The Sprague-Dawley rat hearts were subjected to 1 h of ischemia plus 3 h of reperfusion, which showed the I/R injury (increase in infarct size and creatine kinase release) and the elevated total and mitochondrial protein levels of Mul1 and p53 accompanied by the enhanced interactions between Mul1 and p53 as well as p53 and small a ubiquitin-like modifier (SUMO1). Consistently, hypoxia/reoxygenation (H/R) treated cardiac (H9c2) cells displayed cellular injury (apoptosis and necrosis), upregulation of total and mitochondrial protein levels of Mul1 and p53, and enhanced interactions between p53 and SUMO1 concomitant with mitochondrial dysfunctions (an increase in mitochondrial membrane potential and reactive oxygen species production with a decrease in ATP production); these phenomena were attenuated by knockdown of Mul1 expression. Based on these observations, we conclude that a novel role of Mul1 has been identified in the myocardial mitochondria, where Mul1 stabilizes and activates p53 through its function of SUMOylation following I/R, leading to p53-mediated mitochondrial dysfunction and cell death.

Entities:  

Keywords:  E3 ubiquitine ligase mitochondriale 1; SUMOylation; hypoxia/reoxygenation; hypoxie/réoxygénation; ischemia/reperfusion; ischémie/reperfusion; lésions myocardiques; mitochondria; mitochondrial E3 ubiquitin ligase 1; mitochondrie; myocardial injury; p53

Mesh:

Substances:

Year:  2019        PMID: 31825666     DOI: 10.1139/cjpp-2019-0285

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  3 in total

1.  SUMOylation of Nuclear γ-Actin by SUMO2 supports DNA Damage Repair against Myocardial Ischemia-Reperfusion Injury.

Authors:  Wei Zhao; Xiuying Zhang; Jia Zhao; Ni Fan; Jianhui Rong
Journal:  Int J Biol Sci       Date:  2022-07-11       Impact factor: 10.750

2.  NR4A2 Exacerbates Cerebral Ischemic Brain Injury via Modulating microRNA-652/Mul1 Pathway.

Authors:  Qiandong Liu; Qinglin Dong
Journal:  Neuropsychiatr Dis Treat       Date:  2020-10-06       Impact factor: 2.570

3.  TRIM38 protects H9c2 cells from hypoxia/reoxygenation injury via the TRAF6/TAK1/NF-κB signalling pathway.

Authors:  Zhengri Lu; Mengen Deng; Genshan Ma; Lijuan Chen
Journal:  PeerJ       Date:  2022-08-29       Impact factor: 3.061

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.